Dagmar Dilloo

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation

Roland Meisel, Andree Zibert, M. D. Laryea et al. · Blood · 2004 · 1.6K citations · Full text

Life Sciences, Immunology, Pharmacology +13

Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

Helmut Hanenberg, Xiang Xiao, Dagmar Dilloo et al. · Nature Medicine · 1996 · 560 citations

Life Sciences, Cell Biology, Molecular Biology +15

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease

Catherine M. Bollard, Laura K. Aguilar, Karin Straathof et al. · The Journal of Experimental Medicine · 2004 · 390 citations · Full text

Life Sciences, Immunology, Oncology +17

Increasing Mixed Chimerism Is an Important Prognostic Factor for Unfavorable Outcome in Children With Acute Lymphoblastic Leukemia After Allogeneic Stem-Cell Transplantation: Possible Role For Pre-Emptive Immunotherapy?

Peter Bader, Hermann Kreyenberg, W Hoelle et al. · Journal of Clinical Oncology · 2004 · 251 citations

Medicine, Hematology, Immunology +16

Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase

Roland Meisel, S Brockers, Kathrin Heseler et al. · Leukemia · 2011 · 250 citations

Life Sciences, Microbiology, Pharmacology +3